QualityStocksNewsBreaks Archives - Page 447 of 1647

TuesdayOct 10, 2023 2:21 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation's esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in autism and related neurodevelopmental disorders and brings together leading scientists, clinicians, biotech and pharmaceutical companies, venture partners, and community stakeholders to foster scientific advancements that can enhance the well-being and quality of life for individuals affected by ASD. “We are honored to support The BRAIN…

TuesdayOct 10, 2023 2:10 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Featured in Latest Episode of The Bell2Bell Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is featured in the latest Bell2Bell Podcast release. During the segment, podcast host Stuart Smith discusses the company with Clene president and CEO Rob Etherington, who explains Clene’s business model and provides an overview of recent developments, which provide hope to those affected by neurodegenerative conditions. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. “Clene spends every waking moment working on amyotrophic lateral sclerosis (‘ALS’), a devastating neurodegenerative condition,” said Clene president…

TuesdayOct 10, 2023 1:53 pm

QualityStocksNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its entry into development collaboration with the University of Arizona Center for Innovation (“UACI”) to propel ABBIE, a non-viral gene-editing kit technology. UACI is a leading science and tech startup incubator that is directly connected to the University of Arizona, which is renowned for its contributions to the scientific community, ranking among the nation’s top 50 public universities by U.S. News & World Report. “We are delighted to assist SOHM and the development of ABBIE technology,” said UACI Executive…

MondayOct 09, 2023 12:40 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Emergency Communication Systems Deployed for Four Existing Customers

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced new purchase orders. The orders are from four existing customers – two cities and two universities – seeking to grow and improve their emergency communications systems. The announcement reads, “Advocates, individuals and government officials at all levels must do everything they can to ensure that schools are safe places for students, teachers and other employees. A university in Delaware is expanding their 15-phone emergency communication system with 3 K1 Blue Light Emergency Phones. A Southern California university added Knightscope’s K1B Maintenance Plan…

MondayOct 09, 2023 11:43 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Marianne McInerney as Chief Strategy Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the appointment of Marianne McInerney as chief strategy officer. According to the announcement, McInerney will focus on growth opportunities and drive strategic initiatives for Mullen’s commercial, consumer vehicles and governmental affairs. McInerney has nearly two decades of experience in the automotive and transportation industry, during which she has advised multiple original equipment manufacturers, governmental entities and tier one suppliers and held vital positions at next-generation vehicle OEMs, the U.S. Department of Transportation, and the American International Automobile Dealers Association. “Marianne is a key addition to our team and…

FridayOct 06, 2023 11:28 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Growth, Momentum with New Emergency Communications Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is seeing consistent success and growth as the company has announced a string of new orders. Most recently, the company has signed three new contracts for five devices to be used by clients in New York, Nevada, and Oklahoma. The new orders represent the value and diversity Knightscope products for an array of uses and across a broad spectrum. The Knightscope devices will be used on a college campus in New York, a park in Oklahoma and a city in Nevada. “The goal of…

ThursdayOct 05, 2023 12:26 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Digital Engagement Engine(TM) Creating Digital Experiences That Drive Growth

Electronic Servitor Publication Network (OTC: XESP) is a digital engagement company offering a Managed Service that provides unique digital activation and engagement solutions to businesses that seek to optimize growth. The company is making a difference in the global customer engagement solutions market. “The company’s Managed Service is powered by a proven, proprietary technology – the Digital Engagement Engine(TM) – which provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action and drive growth. Electronic Servitor Publication Network’s Digital Engagement Engine(TM) was designed to drive growth for…

ThursdayOct 05, 2023 12:14 pm

QualityStocksNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces ACS Donation, ‘Spin for a Cure’ Event

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, today announced a planned donation of $10,000 to the American Cancer Society (“ACS”) in honor of Breast Cancer Awareness Month. According to the update, DoubleDown Casino, which is played daily by millions of fans worldwide on both desktop and mobile devices, will invite players to engage with and show support for the charitable donation by taking part in a play-to-enter giveaway on Oct. 11, 2023. The “Spin for a Cure” event offers players the chance to express their enthusiasm for helping the American…

ThursdayOct 05, 2023 12:05 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Reports Top-Line Results for Phase 2a Lomecel-B Clinical Trial

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has released top-line results for its phase 2a trial of its investigational product Lomecel-B(TM). The study evaluated Lomecel-B for the treatment of mild Alzheimer’s disease. According to the report, the primary endpoint of safety was met across all study groups; in addition, the secondary endpoint of change from baseline to week 39 in Composite Alzheimer’s Disease Score (“CADS”) also demonstrated positive results. The report also noted that other doses demonstrated numerical…

ThursdayOct 05, 2023 11:29 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $45.1M NINDS Grant to Support Expanded Access Protocol for CNM-Au8(R) in ALS

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, was awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”), a division of the National Institutes of Health (“NIH”). The grant is to support an Expanded Access Protocol (“EAP”) for the company’s investigational drug, CNM-Au8(R), in amyotrophic lateral sclerosis (“ALS”). Also referred to as Compassionate Use, an EAP is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S.…

Site Search

Company Search

Category: QualityStocksNewsBreaks